Lorraine leads AusBiotech as its Chief Executive Officer and managing director and has worked as a dedicated advocate for the biotechnology sector since joining AusBiotech almost a decade ago. In this role she works closely with public policy impacting the life sciences sector at state and Federal levels, including economic development, tax incentives, patent protection, medical research and its commercialisation.
Lorraine works with the broad biotechnology community and AusBiotech’s 3,000 members to inform and support industry development and has previously held the roles of Deputy CEO, Chief Industry Affairs Officer and National Communications and Media Manager at AusBiotech.
Prior to joining AusBiotech, Lorraine has worked in corporate and public affairs roles for a multinational biopharmaceutical company, the Pharmacy Guild of Australia, the University of Melbourne and for a (mental) health consumer organisation as an advocate.
Lorraine has an undergraduate degree in public relations, majoring in journalism, a postgraduate diploma in marketing management, an MBA and is a graduate of the Australian Institute of Company Directors.
She currently sits on the Research and Development Tax Incentive Roundtable, the CSIRO Manufacturing Business Unit Advisory Committee, the International Council of Biotechnology Associations, the Federal Government’s Clinical Trials Collaborative Forum and the Global Talent Scheme (GTS) start-up advisory panel, the University of Melbourne’s Master of Biotechnology Advisory Group, is a Director of the Agricultural Biotechnology Council of Australia, Deputy-Chair of the Australia China Business Council’s (VIC) Health and Medical Research Committee, on the Early Phase Clinical Trials Oversight Committee for NSW Health and sits on Swinburne University’s Advisory Board for the Centre for Human Psychopharmacology.